Dermawan, J. K. T., Nafa, K., Mohanty, A., Xu, Y., Rijo, I., Casanova, J., Villafania, L., Benhamida, J., Kelly, C. M., Tap, W. D., Boland, P. J., Fabbri, N., Healey, J. H., Ladanyi, M., Lu, C., & Hameed, M. (2023). Distinct IDH1/2-associated Methylation Profile and Enrichment ofTP53andTERTMutations Distinguish Dedifferentiated Chondrosarcoma from Conventional Chondrosarcoma. Cancer Research Communications, 3(3), 431–443. https://doi.org/10.1158/2767-9764.crc-22-0397

Sheikh, T. N., Chen, X., Xu, X., McGuire, J. T., Ingham, M., Lu, C., & Schwartz, G. K. (2021). Growth Inhibition and Induction of Innate Immune Signaling of Chondrosarcomas with Epigenetic Inhibitors. Molecular Cancer Therapeutics, 20(12), 2362–2371. https://doi.org/10.1158/1535-7163.mct-21-0066